agilon health, inc. (AGL)
NYSE: AGL · Real-Time Price · USD
84.14
+1.86 (2.26%)
Oct 2, 2026, 4:00 PM EDT - Market closed
agilon health Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 5,920 | 5,933 | 6,061 | 4,316 | 2,388 | 1,521 |
Revenue Growth | 0.32% | -2.11% | 40.41% | 80.74% | 56.96% | 24.88% |
Gross Profit Gross Profit Growth | 13.84 | -160.02 | 4.84 | 69.67 | 111.36 | 65.74 |
Operating Income Operating Income Growth | -254.07 | -421.08 | -283.96 | -231.95 | -102.91 | -366.84 |
Net Income Net Income Growth | -232.22 | -391.35 | -260.15 | -262.6 | -106.55 | -406.49 |
Earnings Per Share EPS Growth | -13.97 | -23.63 | -15.83 | -16.05 | -6.53 | -27.25 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Medical Services Medical Services Growth | 5,911 | 5,921 | 6,048 | 4,307 | 2,385 | 1,518 |
Other Operating Other Operating Growth | 9.12 | 11.24 | 12.82 | 9.01 | 3.33 | 3.17 |
Revenue (Total) Revenue (Total) Growth | 5,920 | 5,933 | 6,061 | 4,316 | 2,388 | 1,521 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 185.63 | 285.14 | 399.97 | 488.34 | 877.2 | 1,040 |
Total Debt Total Debt Growth | 33.45 | 36.82 | 41.5 | 46.06 | 56.02 | 59.61 |
Net Cash (Debt) Net Cash Growth | 152.18 | 248.33 | 358.47 | 442.28 | 821.18 | 980.43 |
Net Cash Growth | -46.72% | -30.73% | -18.95% | -46.14% | -16.24% | 3146.02% |
Net Cash Per Share Net Cash Per Share Growth | 9.16 | 15.00 | 21.81 | 27.04 | 50.30 | 65.72 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -72.26 | -105.76 | -57.78 | -156.2 | -130.81 | -148.16 |
Capital Expenditures CapEx Growth | -12.69 | -13.24 | -13.25 | -15.83 | -15.43 | -6.56 |
Free Cash Flow Free Cash Flow Growth | -84.95 | -119.01 | -71.03 | -172.03 | -146.23 | -154.72 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 0.23% | -2.70% | 0.08% | 1.61% | 4.66% | 4.32% |
Operating Margin | -4.29% | -7.10% | -4.69% | -5.37% | -4.31% | -24.11% |
Pretax Margin | -4.23% | -6.81% | -4.11% | -4.51% | -3.80% | -25.17% |
Profit Margin | -3.92% | -6.60% | -4.29% | -6.08% | -4.46% | -26.72% |
FCF Margin | -1.44% | -2.01% | -1.17% | -3.99% | -6.12% | -10.17% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | 49.52 | 245.94 | 245.94 | 245.94 | - | - |
PS Ratio | 0.24 | 0.05 | 0.13 | 1.18 | 2.78 | 6.99 |